Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 75.20% is in line with its 5-year average of 72.68%, near the high end of its 5-year range (58.26%–79.04%).
0.87% below its 12-month average of 75.86%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 76.23%.
GROSS MARGIN
75.20%
GROSS MARGIN AVG TTM
75.86%
GROSS MARGIN AVG 3Y
75.28%
GROSS MARGIN AVG 5Y
72.68%
GROSS MARGIN AVG 10Y
66.58%
GROSS MARGIN AVG 15Y
69.39%
GROSS MARGIN AVG 20Y
68.30%
CURRENT VS TTM AVG
-0.87%
CURRENT VS 3Y AVG
-0.10%
CURRENT VS 5Y AVG
+3.47%
CURRENT VS 10Y AVG
+12.95%
CURRENT VS 15Y AVG
+8.38%
CURRENT VS 20Y AVG
+10.11%
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+82.50%
vs the sector median at left
SANUWAVE Health Inc.
Market Cap
$44.71M
Gross Margin
75.20%
TTM Avg
75.86%
3Y Avg
75.28%
5Y Avg
72.68%
Market Cap
$44.72M
Gross Margin
0.00%
TTM Avg
1.89%
3Y Avg
44.91%
5Y Avg
29.94%
Market Cap
$44.02M
Gross Margin
56.09%
TTM Avg
52.85%
3Y Avg
42.50%
5Y Avg
40.42%
Market Cap
$42.83M
Gross Margin
-98.21%
TTM Avg
-96.12%
3Y Avg
-84.75%
5Y Avg
-75.83%
Market Cap
$42.72M
Gross Margin
22.65%
TTM Avg
11.13%
3Y Avg
-12.99%
5Y Avg
-22.58%
Market Cap
$42.26M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SANUWAVE Health Inc. (SNWV) | $44.71M | 75.20% | 75.86% | 75.28% | 72.68% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | 0.00% | 1.89% | 44.91% | 29.94% |
| DarioHealth Corp. (DRIO)vs › | $44.02M | 56.09% | 52.85% | 42.50% | 40.42% |
| Celularity Inc. (CELU)vs › | $45.73M | 79.62% | 74.20% | 42.17% | 48.15% |
| CVRx, Inc. (CVRX)vs › | $42.99M | 86.60% | 84.54% | 82.73% | 79.87% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | -98.21% | -96.12% | -84.75% | -75.83% |
| Instil Bio, Inc. (TIL)vs › | $46.69M | 0.00% | 0.00% | 0.00% | 16.67% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | 22.65% | 11.13% | -12.99% | -22.58% |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | 0.00% | 0.00% | 0.00% | 0.00% |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | 93.13% | 94.29% | 92.05% | 80.64% |
Gross Margin
75.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 76.23% |
| 2026-03-31 | 74.70% |
| 2025-12-31 | 74.10% |
| 2025-09-30 | 76.00% |
| 2025-06-30 | 78.30% |
| 2025-03-31 | 79.04% |
| 2024-12-31 | 77.87% |
| 2024-09-30 | 75.50% |
| 2024-06-30 | 73.16% |
| 2024-03-31 | 72.62% |
| 2023-12-31 | 66.43% |
| 2023-09-30 | 71.49% |
| 2023-06-30 | 74.29% |
| 2023-03-31 | 66.57% |
| 2022-12-31 | 68.35% |
| 2022-09-30 | 72.23% |
| 2022-06-30 | 71.77% |
| 2022-03-31 | 72.18% |
| 2021-12-31 | 68.83% |
| 2021-09-30 | 58.26% |
| 2021-06-30 | 63.97% |
| 2021-03-31 | 50.14% |
| 2020-12-31 | 73.19% |
| 2020-09-30 | 56.00% |
| 2020-06-30 | 4.82% |
| 2020-03-31 | 12.75% |
| 2019-12-31 | 59.46% |
| 2019-09-30 | 37.80% |
| 2019-06-30 | 41.36% |
| 2019-03-31 | 47.26% |
| 2018-12-31 | 61.04% |
| 2018-09-30 | 69.18% |
| 2018-06-30 | 63.23% |
| 2018-03-31 | 51.94% |
| 2017-12-31 | 68.25% |
| 2017-09-30 | 61.83% |
| 2017-06-30 | 77.76% |
| 2017-03-31 | 63.13% |
| 2016-12-31 | 51.32% |
| 2016-09-30 | 61.40% |
| 2016-06-30 | 61.66% |
| 2016-03-31 | 72.83% |
| 2015-12-31 | 69.95% |
| 2015-09-30 | 73.01% |
| 2015-06-30 | 68.42% |
| 2015-03-31 | 72.05% |
| 2014-12-31 | 70.35% |
| 2014-09-30 | 70.07% |
| 2014-06-30 | 73.37% |
| 2014-03-31 | 87.36% |
| 2013-12-31 | 72.14% |
| 2013-09-30 | 80.15% |
| 2013-06-30 | 85.19% |
| 2013-03-31 | 72.27% |
| 2012-12-31 | 84.26% |
| 2012-09-30 | 75.34% |
| 2012-06-30 | 60.94% |
| 2012-03-31 | 69.91% |
| 2011-12-31 | 67.66% |
| 2011-09-30 | 70.02% |
| 2011-06-30 | 71.16% |
| 2011-03-31 | 62.94% |
| 2010-12-31 | 72.65% |
| 2010-09-30 | 60.53% |
| 2010-06-30 | 65.08% |
| 2010-03-31 | 66.71% |
| 2009-12-31 | 20.94% |
| 2009-09-30 | 77.18% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
